Poster Session Po4-1 to 4-70

Autor: Dcw Siu, CP Lau, MH Jim, Awc Kung, Hung-Fat Tse, X Zhang

Publikováno v: Heart Rhythm. 5:S259-S284

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8babcdc3aa0e48abd593ec25f79f564f
https://doi.org/10.1016/j.hrthm.2008.03.049

Consensus statement on the management of hyperkalaemia-An Asia-Pacific perspective.

Autor: Yap DYH; Division of Nephrology, Department of Medicine, University of Hong Kong, Hong Kong SAR, China., Ma RCW; Division of Endocrinology and Diabetes, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China., Wong ECK; Cardiology Division, Department of Medicine, University of Hong Kong, Hong Kong SAR, China., Tsui MSH; Department of Accident and Emergency, Queen Mary Hospital, Hong Kong SAR, China., Yu EYT; Department of Family Medicine and Primary Care, University of Hong Kong, Hong Kong SAR, China., Yu V; Department of Dietetics, Queen Mary Hospital, Hong Kong SAR, China., Szeto CC; Division of Nephrology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China., Pang WF; Division of Nephrology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China., Tse HF; Cardiology Division, Department of Medicine, University of Hong Kong, Hong Kong SAR, China., Siu DCW; Cardiology Division, Department of Medicine, University of Hong Kong, Hong Kong SAR, China., Tan KCB; Endocrinology and Metabolism Division, Department of Medicine, University of Hong Kong, Hong Kong SAR, China., Chen WWC; Division of Cardiology, Virtus Medical Group, Hong Kong SAR, China., Li CL; Division of Nephrology, Centro Hospitalar Conde de São Januário, Macau SAR, China., Chen W; Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China., Chan TM; Division of Nephrology, Department of Medicine, University of Hong Kong, Hong Kong SAR, China.

Publikováno v: Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2024 Jun; Vol. 29 (6), pp. 311-324. Date of Electronic Publication: 2024 Feb 25.

Carditis After COVID-19 Vaccination With a Messenger RNA Vaccine and an Inactivated Virus Vaccine : A Case-Control Study.

Autor: Lai FTT; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, and Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China (F.T.T., E.W.Y.)., Li X; Department of Medicine and Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, and Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China (X.L.)., Peng K; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China (K.P., L.H.)., Huang L; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China (K.P., L.H.)., Ip P; Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China (P.I.)., Tong X; Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China (X.T., D.C.W.)., Chui CSL; Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Science and Technology Park, and the School of Nursing and School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China (C.S.L.)., Wan EYF; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, and Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, The University of Hong Kong, and Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China (E.Y.F., C.K.H.)., Wong CKH; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, and Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, The University of Hong Kong, and Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China (E.Y.F., C.K.H.)., Chan EWY; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, and Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China (F.T.T., E.W.Y.)., Siu DCW; Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China (X.T., D.C.W.)., Wong ICK; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, and Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China, and Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom (I.C.K.).

Publikováno v: Annals of internal medicine [Ann Intern Med] 2022 Mar; Vol. 175 (3), pp. 362-370. Date of Electronic Publication: 2022 Jan 25.

Different glycaemia-related risk factors for incident Alzheimer's disease in men and women with type 2 diabetes-A sex-specific analysis of the Hong Kong diabetes database.

Autor: Lee CH; State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong, Hong Kong, China.; Department of Medicine, University of Hong Kong, Hong Kong, China., Lui DTW; Department of Medicine, University of Hong Kong, Hong Kong, China., Cheung CYY; Department of Medicine, University of Hong Kong, Hong Kong, China., Woo YC; Department of Medicine, University of Hong Kong, Hong Kong, China., Fong CHY; Department of Medicine, University of Hong Kong, Hong Kong, China., Yuen MMA; Department of Medicine, University of Hong Kong, Hong Kong, China., Shea YF; Department of Medicine, University of Hong Kong, Hong Kong, China., Siu DCW; Department of Medicine, University of Hong Kong, Hong Kong, China., Chan KH; Department of Medicine, University of Hong Kong, Hong Kong, China., Chow WS; Department of Medicine, University of Hong Kong, Hong Kong, China., Lam KSL; State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong, Hong Kong, China.; Department of Medicine, University of Hong Kong, Hong Kong, China.

Publikováno v: Diabetes/metabolism research and reviews [Diabetes Metab Res Rev] 2021 Sep; Vol. 37 (6), pp. e3401. Date of Electronic Publication: 2020 Sep 11.

Parkinson disease and leucine-rich repeat kinase 2 gene mutation: abridged secondary publication.

Autor: Ho SL; Division of Neurology, Department of Medicine, The University of Hong Kong., Ho PWL; Division of Neurology, Department of Medicine, The University of Hong Kong., Siu DCW; Division of Neurology, Department of Medicine, The University of Hong Kong.

Publikováno v: Hong Kong medical journal = Xianggang yi xue za zhi [Hong Kong Med J] 2020 Dec; Vol. 26 Suppl 8 (6), pp. 22-26.